Press Room

Duchesnay Inc. is pleased to announce that Health Canada has granted market authorization for Mictoryl®/Mictoryl® Pediatric

Read more >

Duchesnay Summarizes Comprehensive Body of Evidence for Most Studied Morning Sickness Drug Worldwide – Over 40 years of clinical experience, 16 cohort studies, two meta-analyses support regulatory approvals and guidelines –

Read more >

Duchesnay donates $12,000 to Moisson Laurentides, surpassing our 2015 contribution of $10,000

Read more >

2015-2016 Excellence Awards at the Université de Montréal Faculty of Pharmacy

Read more >

Duchesnay Launches New Formulation of its Pregvit® and Pregvit® Folic 5 Prenatal Vitamins

Read more >

Duchesnay obtains exclusive canadian commercial rights to Fluomizin™, indicated for the treatment of vaginal infections

Read more >